Category Archives: Pr Newswire

Innovent to Present Multiple Clinical Study Results of Mazdutide at the ADA’s 84th Scientific Sessions

SAN FRANCISCO and SUZHOU, China, June 12, 2024 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology and other major diseases, announces that it will present multiple clinical study results of mazdutide at the American Diabetes […]

Ultragenyx and Mereo BioPharma Announce New Phase 2 Data from Phase 2/3 Orbit Study Demonstrating Sustained Reductions in Fracture Rates Following Treatment with Setrusumab (UX143) in Patients with Osteogenesis Imperfecta (OI)

14-month data show treatment with setrusumab resulted in a large, sustained 67% reduction in annualized fracture rate and persistent median annualized fracture rate of 0.00 (p=0.0014) Treatment resulted in continued, substantial improvements in bone mineral density (BMD) with a mean increase from baseline of 22% (p<0.0001) and a mean improvement in Z-score of +1.25 (p<0.0001) NOVATO, Calif. […]

Tonix Pharmaceuticals Announces Proposed Public Offering

CHATHAM, N.J., June 11, 2024 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated biopharmaceutical company, today announced that it intends to offer and sell shares of its common stock (or pre-funded warrants in lieu thereof). All of the securities to be sold in the offering are to be offered by […]

NIRA Dynamics’ Wheel Safety solutions would annually prevent hundreds of accidents caused by wheel detachments

LINKÖPING, Sweden, June 11, 2024 /PRNewswire/ — Following the Swedish Tire Safety Council’s alarming report on wheel detachment incidents, NIRA Dynamics reaffirms the value of its pioneering Loose Wheel Indicator (LWI) technology. Established in the market since 2017 and currently enhancing over 1 million vehicles, including Audi’s fleet, LWI represents a significant leap in automotive safety, […]

ROHM’s New “TRCDRIVE pack (TM)” with 2-in-1 SiC Molded Module: Significantly Reduces xEV Inverter Size

– Industry-leading* Power Density Achieved by Integrating 4th Generation SiC MOSFETs in Compact Package – KYOTO, Japan, June 11, 2024 /PRNewswire/ — ROHM Co., Ltd. has developed four models as part of the TRCDRIVE pack (TM) series with 2-in-1 SiC molded modules (two of 750V-rated: BSTxxxD08P4A1x4, two of 1,200V-rated: BSTxxxD12P4A1x1) optimized for xEV (electric vehicles) traction […]

XTransfer and Banking Circle Announce Strategic Partnership

Collaboration Set to Boost Payment Capabilities for Importers/Exporters in Europe and the Middle East HONG KONG, June 11, 2024 /PRNewswire/ — XTransfer, the World’s Leading & China’s No.1 B2B Cross-Border Trade Payment Platform, and Banking Circle, the innovative tech-driven Payments Bank, have entered into a strategic partnership. This collaboration aims to reduce the cost and […]

Alvotech and STADA add to Strategic Alliance through Denosumab Partnership

STADA assumes marketing license for Alvotech’s proposed biosimilar referencing Prolia®/Xgeva® (denosumab) in Europe, including Switzerland and the UK, as well as rights in selected markets in Central Asia and the Middle East This partnership for the osteoporosis and cancer-related molecule builds on the two company’s existing strategic alliance in Europe. The first product launched through […]

Alvotech and STADA add to strategic alliance through denosumab partnership

STADA assumes marketing license for Alvotech’s proposed biosimilar referencing Prolia®/Xgeva® (denosumab) in Europe, including Switzerland and the UK, as well as rights in selected markets in Central Asia and the Middle East This partnership for the osteoporosis and cancer-related molecule builds on the two company’s existing strategic alliance in Europe. The first product launched through […]

Bright Peak Therapeutics Announces $90 Million in Series C Financing to Advance First-in-Class PD1-IL18 Immunoconjugate Program Into Clinical Trials

— Lead Program, BPT567, will be the first PD1-IL18 immunoconjugate to enter the clinic; Phase 1/2a study in solid tumors expected to begin in 2H 2024 – — Financing led by Johnson & Johnson with participation by new and existing investors– BASEL, Switzerland and SAN DIEGO, June 11, 2024 (GLOBE NEWSWIRE) — Bright Peak Therapeutics, […]

NIRA Dynamics’ Wheel Safety solutions would annually prevent hundreds of accidents caused by wheel detachments

LINKÖPING, Sweden, June 11, 2024 /PRNewswire/ — Following the Swedish Tire Safety Council’s alarming report on wheel detachment incidents, NIRA Dynamics reaffirms the value of its pioneering Loose Wheel Indicator (LWI) technology. Established in the market since 2017 and currently enhancing over 1 million vehicles, including Audi’s fleet, LWI represents a significant leap in automotive safety, […]